TrialJournal of neuro-oncology2010

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide.

Gregor Dresemann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.